BriClone is an additive for the cloning medium used in the post-fusion stages of hybridoma production and for improving the efficiency of hybridoma cell cloning.
The NICB’s state-of-the-art proteomics and mass spectrometry core facility supports many research programmes in the NICB.
The NICB (National Institute for Cellular Biotechnology) is located on the Dublin City University (DCU) campus in North Dublin.
It is a leading multidisciplinary centre of translational research in Fundamental and Applied Cellular Biotechnology, Molecular Cell Biology, Ocular Diseases and Biological Chemistry. It includes a multidisciplinary team of Cell and Molecular Biologists, Biotechnologists, Chemists and Informatics specialists.
The NICB prioritises translational research involving collaborations with industry and with clinicians, and is committed to educating people from all backgrounds in the area of Biomedical Science.
This field represents an important opportunity for future development of the pharmaceutical industry and a significant area for employment of scientists in Ireland.
Cancer research at NICB aims to apply the powerful techniques associated with cell and molecular biology to gaining a deeper understanding of human cancer and how it might be better detected, treated and monitored.
In collaboration with medical transplant teams we are currently undertaking basic laboratory process optimization which could lead to development of a National Islet Cell Transplantation Programme to help treat Type 1 Diabetes.
The NICB is directly involved in work leading on to clinical application for corneal stem cell transplant and pancreatic islet transplant for treatment of type 1 diabetes. We are also studying the interaction of metals with cells.
The NICB is involved in the development and application of targeted molecular libraries and is now increasingly active in the field of hybrid materials for biological applications.